FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stephen Devereux

Research Profile

Procedures

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
Pramila Krishnamurthy; Austin G Kulasekararaj; Zi Yi Lim; Judith C W Marsh; Linda D Barber; Hugues de Lavallade; Stephen Devereux; Robin M Ireland; Michelle Kenyon; Antonio Pagliuca; Rachel M Pearce; Victoria T Potter; Ghulam J Mufti
Outcome of donor lymphocyte infusion after T cell-depleted allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndromes.
Emma Hamilton; Liam Morgan; Laurence Pearce; Paul Brennan; Andrea G S Buggins; Stephen Devereux; Christopher Fegan; Sophie Robinson; N Shaun B Thomas; Vicki Ware; Deborah Yallop; Chris Pepper
Mimicking the tumour microenvironment: three different co-culture systems induce a similar phenotype but distinct proliferative signals in primary chronic lymphocytic leukaemia cells.
M Mansour Ceesay; Stephen Devereux; Paul Fields; Aloysius Ho; Estella Matutes; Ghulam J Mufti; Sylwia Simpson; Graham P Taylor; Jamie Cavenagh; ANTONIO PAGLIUCA
Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stephen Devereux (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Pramila Krishnamurthy; Austin G Kulasekararaj; Zi Yi Lim; Judith C W Marsh; Linda D Barber; Hugues de Lavallade; Stephen Devereux; Robin M Ireland; Michelle Kenyon; Antonio Pagliuca; Rachel M Pearce; Victoria T Potter; Ghulam J Mufti
Outcome of donor lymphocyte infusion after T cell-depleted allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndromes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(4):562-8.
2012: Emma Hamilton; Liam Morgan; Laurence Pearce; Paul Brennan; Andrea G S Buggins; Stephen Devereux; Christopher Fegan; Sophie Robinson; N Shaun B Thomas; Vicki Ware; Deborah Yallop; Chris Pepper
Mimicking the tumour microenvironment: three different co-culture systems induce a similar phenotype but distinct proliferative signals in primary chronic lymphocytic leukaemia cells.
British journal of haematology 2012;158(5):589-99.
2012: M Mansour Ceesay; Stephen Devereux; Paul Fields; Aloysius Ho; Estella Matutes; Ghulam J Mufti; Sylwia Simpson; Graham P Taylor; Jamie Cavenagh; ANTONIO PAGLIUCA
Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL).
Leukemia research 2012;36(7):857-61.
2011: Shreyans A Gandhi; Stephen Devereux; Ghulam Mufti; Robin Ireland
Primary effusion lymphoma in an HIV-negative man.
British journal of haematology 2011;155(4):411.
2011: Andrea G S Buggins; Yolanda Calle; Keith Fishlock; Satyen Gohil; Ana Levi; Piers E M Patten; Deborah Yallop; Stephen Devereux
Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP-9.
British journal of haematology 2011;154(2):216-22.
2011: Aneela Majid; Fiona Miall; David G Oscier; Guy Pratt; Simon Wagner; Deborah Yallop; Giles Best; Andrea G S Buggins; Stephen Devereux; Martin J S Dyer; Chris Fegan; Keith Fishlock; Saman Hewamana; Robert Hills; Ben J Kennedy; Thet Thet Lin; Chris Pepper
CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL.
Leukemia research 2011;35(6):750-6.
2010: Andrea G S Buggins; Chris Pepper; Piers E M Patten; Saman Hewamana; Satyen Gohil; Jane Moorhead; Najeem'deen Folarin; Deborah Yallop; N Shaun B Thomas; Ghulam J Mufti; Christopher Fegan; Stephen Devereux
Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcription.
Cancer research 2010;70(19):7523-33.
2010: Ziyi Lim; Wendy Ingram; Ronald Brand; A Ho; Michelle Kenyon; Stephen Devereux; J Marsh; Ghulam J Mufti; ANTONIO PAGLIUCA
Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML.
Bone marrow transplantation 2010;45(4):633-9.
2008: Wendy Ingram; Stephen Devereux; Emma P Das-Gupta; Nigel H Russell; Andrew P Haynes; Jennifer L Byrne; Bronwen E Shaw; Andrew McMillan; Juan Gonzalez; Aloysius Ho; Ghulam J Mufti; ANTONIO PAGLIUCA
Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma.
British journal of haematology 2008;141(2):235-43.
2007: Piers E M Patten; Stephen Devereux
Lymphoma diagnosis: an update.
Clinical medicine (London, England) 2007;7(6):620-4.
2007: Ziyi Lim; Wendy Ingram; R Brand; M Akthari; Dragana Milojkovic; Aloysius Y Ho; Stephen Devereux; ANTONIO PAGLIUCA; R F Duarte; Ghulam J Mufti
Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation: association with chronic graft-versus-host disease and improved overall survival.
Bone marrow transplantation 2007;40(8):747-52.
2007: Daniel Creamer; Claire L Martyn-Simmons; G E N Osborne; Michelle Kenyon; Jonathan R Salisbury; Stephen Devereux; ANTONIO PAGLIUCA; Aloysius Y Ho; Ghulam J Mufti; A W P Du Vivier
Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
Archives of dermatology 2007;143(9):1157-62.
2007: Ziyi Lim; Laurence Pearce; Aloysius Y Ho; Linda Barber; Wendy Ingram; Monica Usai; Khalid Tobal; Stephen Devereux; ANTONIO PAGLIUCA; Ghulam J Mufti
Delayed attainment of full donor chimaerism following alemtuzumab-based reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes.
British journal of haematology 2007;138(4):517-26.
2007: Ziyi Lim; Aloysius Y Ho; Stephen Devereux; Ghulam J Mufti; ANTONIO PAGLIUCA; J Wade; M Smith
False positive results of galactomannan ELISA assay in haemato-oncology patients: a single centre experience.
The Journal of infection 2007;55(2):201-2.
2007: J M L White; Daniel Creamer; A W P Du Vivier; ANTONIO PAGLIUCA; Aloysius Y Ho; Stephen Devereux; Jonathan R Salisbury; Ghulam J Mufti
Sclerodermatous graft-versus-host disease: clinical spectrum and therapeutic challenges.
The British journal of dermatology 2007;156(5):1032-8.
2007: Karthik Ramasamy; Ziyi Lim; ANTONIO PAGLIUCA; Stephen Devereux; Aloysius Y Ho; Ghulam J Mufti
Acute myeloid leukaemia presenting with mediastinal myeloid sarcoma: report of three cases and review of literature.
Leukemia & lymphoma 2007;48(2):290-4.
2007: Ziyi Lim; ANTONIO PAGLIUCA; Sylwia Simpson; Simon Cottam; Max Ervine; Aloysius Y Ho; Stephen Devereux; Ghulam J Mufti
Outcomes of patients with haematological malignancies admitted to intensive care unit. A comparative review of allogeneic haematopoietic stem cell transplantation data.
British journal of haematology 2007;136(3):448-50.
2007: Ziyi Lim; Bob Baker; Mark Zuckerman; Mark Zuckermann; Jim J Wade; Mansour Ceesay; Aloysius Y Ho; Stephen Devereux; Ghulam J Mufti; ANTONIO PAGLIUCA
Toxoplasmosis following alemtuzumab based allogeneic haematopoietic stem cell transplantation.
The Journal of infection 2007;54(2):e83-6.
2006: S E Moses; Ziyi Lim; M Sudhanva; Stephen Devereux; Aloysius Y Ho; ANTONIO PAGLIUCA; Mark Zuckerman; Ghulam J Mufti
Lamivudine prophylaxis and treatment of hepatitis B Virus-exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab.
Journal of medical virology 2006;78(12):1560-3.
2006: K Ramasamy; Ziyi Lim; ANTONIO PAGLIUCA; R Grundy; Stephen Devereux; Aloysius Y Ho; Ghulam J Mufti
Incidence and management of hepatic venoocclusive disease in 237 patients undergoing reduced-intensity conditioning (RIC) haematopoietic stem cell transplantation (HSCT).
Bone marrow transplantation 2006;38(12):823-4.
2006: Ziyi Lim; Aloysius Y Ho; Wendy Ingram; Michelle Kenyon; Laurence Pearce; Barbara Czepulkowski; Stephen Devereux; Rafael F Duarte; ANTONIO PAGLIUCA; Ghulam J Mufti
Outcomes of alemtuzumab-based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes.
British journal of haematology 2006;135(2):201-9.
2006: D Milojković; M Aldouri; ANTONIO PAGLIUCA; Ghulam J Mufti; Stephen Devereux
Prolonged remission in a case of Richter's transformation of B-cell chronic lymphocytic leukaemia following adoptive immunotherapy.
Bone marrow transplantation 2006;38(6):461-2.
2006: J M L White; Stephen Devereux; ANTONIO PAGLIUCA; Jonathan R Salisbury; A W P Du Vivier; Daniel Creamer
Koebnerizing sclerodermatous graft-versus-host disease caused by donor lymphocyte infusion and interferon-alpha.
The British journal of dermatology 2006;155(3):621-3.
2006: Karthik Ramasamy; Ziyi Lim; ANTONIO PAGLIUCA; Jonathan R Salisbury; Ghulam J Mufti; Stephen Devereux
Successful treatment of refractory angioimmunoblastic T-cell lymphoma with thalidomide and dexamethasone.
Haematologica 2006;91(8 Suppl):ECR44.
2006: Sunil Gupta; Antonio Pagliuca; Stephen Devereux; Ghulam J Mufti; Steve Schey
Life-threatening motor neurotoxicity in association with bortezomib.
Haematologica 2006;91(7):1001.
2005: Ziyi Lim; R Grace; Jonathan R Salisbury; Daniel Creamer; A Jayaprakasam; Aloysius Y Ho; Stephen Devereux; Ghulam J Mufti; ANTONIO PAGLIUCA
Cardiac presentation of ALK positive anaplastic large cell lymphoma.
European journal of haematology 2005;75(6):511-4.
2005: Bronwen E Shaw; Nigel H Russell; Stephen Devereux; Emma Das-Gupta; Stephen Mackinnon; J Alejandro Madrigal; Anthony Pagliuca; Ghulam J Mufti; Jennifer L Byrne
The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors.
Haematologica 2005;90(11):1562-9.
2005: GK Perera; Stephen Devereux; Ghulam Mufti; Jonathan Salisbury; Daniel Creamer
PNP with Waldenström's macroglobulinaemia.
Clinical and experimental dermatology 2005;30(1):27-9.
2005: Lucas Chan; Nicola R Hardwick; David Darling; Joanna Galea-Lauri; Joop Gäken; Stephen Devereux; Mike Kemeny; Ghulam Mufti; Farzin Farzaneh
IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AML.
Molecular therapy : the journal of the American Society of Gene Therapy 2005;11(1):120-31.
2004: Dragana Milojkovic; Stephen Devereux; Nigel B Westwood; Ghulam J Mufti; N Shaun B Thomas; Andrea G S Buggins
Antiapoptotic microenvironment of acute myeloid leukemia.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(11):6745-52.
2004: Aloysius Y Ho; ANTONIO PAGLIUCA; Michelle Kenyon; Jane E Parker; Aleksandar Mijovic; Stephen Devereux; Ghulam J Mufti
Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning.
Blood 2004;104(6):1616-23.
2004: Rowena D Faulkner; Charles Craddock; Jennifer L Byrne; Premini Mahendra; Andrew P Haynes; H Grant Prentice; Michael Potter; ANTONIO PAGLIUCA; Aloysius Ho; Stephen Devereux; Grant McQuaker; Ghulam Mufti; John Liu Yin; Nigel H Russell
BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients.
Blood 2004;103(2):428-34.
2003: Aloysius Y Ho; Stephen Devereux; Ghulam J Mufti; ANTONIO PAGLIUCA
Reduced-intensity rituximab-BEAM-CAMPATH allogeneic haematopoietic stem cell transplantation for follicular lymphoma is feasible and induces durable molecular remissions.
Bone marrow transplantation 2003;31(7):551-7.
2003: Aloysius Y Ho; Michelle Kenyon; Ihab El-Hemaidi; Stephen Devereux; ANTONIO PAGLIUCA; Ghulam J Mufti
Reduced-intensity allogeneic hematopoietic stem cell transplantation with alemtuzumab conditioning regimens: survival does not plateau until after day 200.
Blood 2003;101(2):779-80.
2002: Kirit M Ardeshna; Arnold Pizzey; Simon J Walker; Stephen Devereux; Asim Khwaja
The upregulation of CC chemokine receptor 7 and the increased migration of maturing dendritic cells to macrophage inflammatory protein 3beta and secondary lymphoid chemokine is mediated by the p38 stress-activated protein kinase pathway.
British journal of haematology 2002;119(3):826-9.
2002: Jane E Parker; Tariq Shafi; ANTONIO PAGLIUCA; Aleksandar Mijovic; Stephen Devereux; Mike Potter; H Grant Prentice; Mamta Garg; John A Yin; Jenny Byrne; Nigel H Russell; Ghulam J Mufti
Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens.
British journal of haematology 2002;119(1):144-54.
2002: Andrea G S Buggins; Ghulam J Mufti; Jonathan Salisbury; Jane Codd; Nigel B Westwood; Matthew Arno; Keith Fishlock; ANTONIO PAGLIUCA; Stephen Devereux
Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab.
Blood 2002;100(5):1715-20.
2002: Simon J Walker; Massimo Pizzato; Yasuhiro Takeuchi; Stephen Devereux
Heparin binds to murine leukemia virus and inhibits Env-independent attachment and infection.
Journal of virology 2002;76(14):6909-18.
2002: Aloysius Y Ho; S Adams; H Shaikh; ANTONIO PAGLIUCA; Stephen Devereux; Ghulam J Mufti
Fatal donor-derived Epstein-Barr virus-associated post-transplant lymphoproliferative disorder following reduced intensity volunteer-unrelated bone marrow transplant for myelodysplastic syndrome.
Bone marrow transplantation 2002;29(10):867-9.
2001: Kirit M Ardeshna; Forhad Ahmed; Stephen Devereux; N Shaun B Thomas
The retinoblastoma family member, p107, is active in non-dividing monocyte-derived dendritic cells.
British journal of haematology 2001;112(3):655-7.
2001: panos kottaridis; Donald W Milligan; Rajesh Chopra; Ronjon Chakraverty; Suparno Chakrabarti; S Robinson; Karl S Peggs; Stephanie Verfuerth; Ruth Pettengell; Judith C W Marsh; Steve Schey; Premini Mahendra; Gareth J Morgan; Geoff Hale; Herman Waldmann; Mary Carmen Ruiz de Elvira; Catherine D Williams; Stephen Devereux; David C Linch; Anthony H Goldstone; Stephen Mackinnon
In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation.
Cytotherapy 2001;3(3):197-201.
2001: T Yeghen; Stephen Devereux
Granulocyte transfusion: a review.
Vox sanguinis 2001;81(2):87-92.
2000: Jane E Parker; Ghulam J Mufti; F Rasool; Aleksandar Mijovic; Stephen Devereux; ANTONIO PAGLIUCA
The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS.
Blood 2000;96(12):3932-8.
2000: panos kottaridis; K Peggs; Stephen Devereux; A H Goldstone; S Mackinnon
Simultaneous occurrence of Clostridium difficile and Cytomegalovirus colitis in a recipient of autologous stem cell transplantation.
Haematologica 2000;85(10):1116-7.
2000: panos kottaridis; Donald W Milligan; Rajesh Chopra; Ronjon Chakraverty; Suparno Chakrabarti; S Robinson; Karl S Peggs; Stephanie Verfuerth; Ruth Pettengell; Judith C W Marsh; Steve Schey; Premini Mahendra; Gareth J Morgan; Geoff Hale; Herman Waldmann; M C de Elvira; Catherine D Williams; Stephen Devereux; David C Linch; Anthony H Goldstone; Stephen Mackinnon
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation.
Blood 2000;96(7):2419-25.
2000: Kirit M Ardeshna; Arnold Pizzey; Stephen Devereux; Asim Khwaja
The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells.
Blood 2000;96(3):1039-46.
2000: Kirit M Ardeshna; Arnold Pizzey; N Shaun B Thomas; S Orr; David C Linch; Stephen Devereux
Monocyte-derived dendritic cells do not proliferate and are not susceptible to retroviral transduction.
British journal of haematology 2000;108(4):817-24.
2000: C Macdonald; S Walker; Michael Watts; Stuart J Ings; David C Linch; Stephen Devereux
Effect of changes in expression of the amphotropic retroviral receptor PiT-2 on transduction efficiency and viral titer: implications for gene therapy.
Human gene therapy 2000;11(4):587-95.
2000: Kirit M Ardeshna; C P Corney; Stuart J Ings; Michael J Watts; David C Linch; Stephen Devereux
A clinically applicable method for the ex vivo generation of antigen-presenting cells from CD34+ progenitors.
Vox sanguinis 2000;79(1):46-52.
2000: Michael J Watts; Stuart J Ings; David Leverett; AK MacMillan; Stephen Devereux; Anthony H Goldstone; David C Linch
ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m(-2) and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients.
British journal of cancer 2000;82(2):278-82.
1999: panos kottaridis; N Ketley; Karl S Peggs; Ronjon Chakraverty; G Ralleigh; P Shaw; F Pezzella; Anthony H Goldstone; Stephen Devereux; Stephen Mackinnon
An unusual case of intrapulmonary granulocytic sarcoma presenting as interstitial pneumonitis following allogeneic bone marrow transplantation for acute myeloid leukaemia and responding to donor lymphocyte infusion.
Bone marrow transplantation 1999;24(7):807-9.
1999: CN Harrison; Walter Gregory; G V Hudson; Stephen Devereux; Anthony H Goldstone; B Hancock; D Winfield; AK MacMillan; P Hoskin; A C Newland; Donald Milligan; David C Linch
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
British journal of cancer 1999;81(3):476-83.
1998: CN Harrison; G Vaughan; Stephen Devereux; David C Linch
Outcome of secondary myeloid malignancy in Hodgkin's disease: the BNLI experience.
European journal of haematology 1998;61(2):109-12.
1998: Michael J Watts; AM Sullivan; David Leverett; Andrew J Peniket; AR Perry; Catherine D Williams; Stephen Devereux; Anthony H Goldstone; David C Linch
Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem-cell mobilization.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1554-60.
1998: Stephen Devereux; C Corney; C Macdonald; Michael Watts; Alexandra Sullivan; A H Goldstone; M Ward; A Bank; David C Linch
Feasibility of multidrug resistance (MDR-1) gene transfer in patients undergoing high-dose therapy and peripheral blood stem cell transplantation for lymphoma.
Gene therapy 1998;5(3):403-8.
1998: Michael J Watts; AM Sullivan; Stuart J Ings; M Barlow; Stephen Devereux; Anthony H Goldstone; David C Linch
Storage of PBSC at -80 degrees C.
Bone marrow transplantation 1998;21(1):111-2.
1997: H Wheadon; Stephen Devereux; Asim Khwaja; David C Linch
Granulocyte-macrophage colony stimulating factor receptor alpha and beta chain complexes can form both high and intermediate affinity functional receptors.
British journal of haematology 1997;98(4):809-18.
1997: Michael J Watts; AM Sullivan; Stuart J Ings; David Leverett; Andrew J Peniket; AR Perry; Catherine D Williams; Stephen Devereux; Anthony H Goldstone; David C Linch
Evaluation of clinical scale CD34+ cell purification: experience of 71 immunoaffinity column procedures.
Bone marrow transplantation 1997;20(2):157-62.
1997: Michael J Watts; AM Sullivan; E Jamieson; Rachel Pearce; A Fielding; Stephen Devereux; Anthony H Goldstone; David C Linch
Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):535-46.
1996: Stephen Devereux; F E Cotter
Anti-sense and gene therapy approaches to the treatment of lymphomas.
Baillière's clinical haematology 1996;9(4):819-34.
1994: H M Wagner; Rosemary E Gale; R W Freeburn; Stephen Devereux; David C Linch
Analysis of mutations in the GM-CSF receptor alpha coding sequence in patients with acute myeloid leukaemia and haematologically normal individuals by RT-PCR-SSCP.
Leukemia 1994;8(9):1527-32.
1990: PJ Roberts; Stephen Devereux; Glenn Pilkington; David C Linch
Fc gamma RII-mediated superoxide production by phagocytes is augmented by GM-CSF without a change in Fc gamma RII expression.
Journal of leukocyte biology 1990;48(3):247-57.
1990: J G Gribben; Stephen Devereux; N Shaun B Thomas; M Keim; Hilary Jones; Anthony H Goldstone; David C Linch
Development of antibodies to unprotected glycosylation sites on recombinant human GM-CSF.
Lancet 1990;335(8687):434-7.
1990: Stephen Devereux; John B Porter; K P Hoyes; R D Abeysinghe; R Saib; David C Linch
Secretion of neutrophil secondary granules occurs during granulocyte-macrophage colony stimulating factor induced margination.
British journal of haematology 1990;74(1):17-23.
1989: I E Addison; B Johnson; Stephen Devereux; Anthony H Goldstone; David C Linch
Granulocyte-macrophage colony-stimulating factor may inhibit neutrophil migration in vivo.
Clinical and experimental immunology 1989;76(2):149-53.
1989: Stephen Devereux; H A Bull; D Campos-Costa; R Saib; David C Linch
Granulocyte macrophage colony stimulating factor induced changes in cellular adhesion molecule expression and adhesion to endothelium: in-vitro and in-vivo studies in man.
British journal of haematology 1989;71(3):323-30.
1989: Stephen Devereux; David C Linch
Clinical significance of the haemopoietic growth factors.
British journal of cancer 1989;59(1):2-5.
1988: David C Linch; Stephen Devereux; I E Addison
The effects of recombinant human granulocyte-macrophage colony-stimulating factor on phagocyte kinetics in man.
Behring Institute Mitteilungen 1988;(83):320-3.
1987: Stephen Devereux; David C Linch; D Campos Costa; M F Spittle; A M Jelliffe
Transient leucopenia induced by granulocyte-macrophage colony-stimulating factor.
Lancet 1987;2(8574):1523-4.